MAKO Surgical, a medical device company focused on minimally invasive orthopedic knee procedures, announced terms for its IPO in a filing with the SEC on Thursday. The company plans to offer 5.1 million shares at an expected price range of $14 to $16 and has applied to have its stock listed on the NASDAQ under the ticker MAKO. JP Morgan and Morgan Stanley are the joint book runners on the deal.
